Which is the biggest pharmaceutical company in China?

Shanghai Pharmaceuticals Holding Co., Ltd is one of the largest national pharmaceutical group in China. Their business covers pharmaceutical R&D, manufacturing, distribution and retailing. In 2015, the Company had reportedly the business revenues of RMB 105.5 billion. It also owns over 1,700 drug stores in total.

How big is the pharmaceutical industry in China?

China’s pharmaceutical market has been constantly growing in recent years. It is estimated to reach $161.8 billion by 2023 and take a 30% share of the global market. As of 2018, China’s pharmaceutical market was valued at $134.6 billion, with prescription medicine uptake accounting for 86.4% of total drug expenditure.

What is the market share of pharmaceutical industry?

The pharmaceutical industry in India is currently valued at $41.7 bn. Generic drugs, with 71% market share, form the largest segment of the Pharmaceutical industry in India. This is set to grow as exports of generics to the US rise, as branded drugs worth $55 bn will become off-patent during 2017-2019.

What country has the largest pharmaceutical market?

The United States
The United States was the largest pharmaceutical market in 2020, generating roughly 46 percent of total revenues worldwide. China established itself as the second-largest market with a sales share of eight percent (altough the statistic shows the hospital market only for China).

How big is the pharmaceutical market in China?

In recent years, China’s demand in the pharmaceutical market has boomed. According to data issued by industry research website chinabaogao.com, in 2018, the terminal market volume of China’s pharmaceutical market reached 1.7 trillion yuan ($242.9 billion), 6.3 percent higher than the same period in 2017.

Which is the fastest growing pharmaceutical market in the world?

Both far outpaced other economies in the world, making China the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expansive market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development.

How much investment does China have in medical industry?

And the capital market also favored the sector. A recent report from Equal Ocean showed that in 2018, China’s medical startups attracted a total investment of $2.7 billion, taking up 7.14 percent of global investment. The figure doubled to $4.5 billion in 2019, accounting for 11.61 percent of global investment.

Where are the growth poles of the pharmaceutical industry?

The two most popular areas of well-developed pharmaceutical industry, called the growth poles, are the Eastern China zone of which Zhejiang province is located in the centre and the South China zone represented by the Guangdong province.